Stephen Chan

Stephen Chan is an experienced oncology account manager currently at Corcept Therapeutics since November 2025. Prior to this, a significant tenure as a hematology clinical account specialist at Pharmacyclics (an AbbVie Company) spanned from April 2018 to October 2025, during which Stephen launched Epkinly (Epcoritumab) and promoted Imbruvica (Ibrutinib) across various territories in Los Angeles and Santa Clara County. A notable role as a senior clinical oncology specialist at Genentech from April 2004 to March 2018 included the promotion of key oncology products such as Herceptin, Perjeta, and Kadcyla. Stephen has received multiple sales excellence awards, demonstrating consistent exceptional performance. Other previous positions include managing oncology sales training at Berlex and serving as a senior account manager at Kaiser Foundation Health Plan. Educational credentials include a BA in Economics from UCLA.